Physician
Great Beginnings Pediatric & Adolescent Medicine, Apmc
Great Beginnings Pediatric & Adolescent Medicine, Apmc was paid $4.07M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 24% of everything it billed.
33Billing provider infoGREAT BEGINNINGS PEDIATRIC & ADOLESCENT MEDICINE, APMC
OPELOUAS, LA 70570
OPELOUAS, LA 70570
33aNPI1841343159assigned 01/19/2007
33bProvider typePediatrics Physician
28Total paid$4.07M
24GClaims189,191
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Louisiana
Rank by total paid#37 of 230
Median peer was paid$429K
This provider vs. median9.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 30,388 | $665K | |
| 2019 | 31,348 | $682K | |
| 2020 | 29,877 | $526K | |
| 2021 | 27,997 | $605K | |
| 2022 | 23,669 | $570K | |
| 2023 | 24,763 | $550K | |
| 2024incomplete | 21,149 | $478K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 24% | 22,673 | 19,917 | $978K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 14% | 8,561 | 7,375 | $556K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 10% | 6,562 | 5,931 | $414K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 10% | 6,567 | 5,947 | $409K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 8.3% | 5,037 | 4,474 | $339K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.2% | 4,957 | 4,665 | $294K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5.5% | 17,504 | 15,437 | $223K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3.7% | 10,852 | 9,780 | $149K |
| 99238 | Hospital discharge day management, 30 minutes or less | 3.0% | 2,574 | 2,289 | $122K |
| 99460 | 2.4% | 2,347 | 2,109 | $96K | |
| 54150 | 2.3% | 826 | 695 | $93K | |
| 92551 | 2.1% | 11,854 | 10,542 | $84K |
56 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.4% | 2,453 | $59K |
| 99462 | 1.0% | 1,883 | $41K | |
| 85018 | <1% | 19,105 | $35K | |
| 90474 | <1% | 3,503 | $29K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 319 | $22K |
| 83655 | <1% | 2,325 | $20K | |
| 99173 | <1% | 12,614 | $20K | |
| 81003 | <1% | 10,662 | $18K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 602 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 855 | $9K |
| 99464 | <1% | 156 | $8K | |
| 0002A | <1% | 321 | $7K | |
| 0001A | <1% | 184 | $6K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 564 | $5K |
| 87807 | <1% | 432 | $5K | |
| 0071A | <1% | 162 | $4K | |
| 0072A | <1% | 102 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 56 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 81 | $2K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 17 | $836.28 |
| 0003A | <1% | 21 | $751.70 | |
| 90620 | <1% | 1,123 | $570.00 | |
| 96160 | <1% | 724 | $411.84 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 116 | $402.78 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 41 | $382.12 |
| 69210 | <1% | 22 | $351.86 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 16 | $90.00 |
| 90670 | <1% | 4,290 | $72.00 | |
| 90686 | <1% | 3,623 | $60.28 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 28 | $50.56 |
| 90651 | <1% | 2,108 | $42.45 | |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 57 | $38.22 |
| 90734 | <1% | 1,218 | $13.52 | |
| 90633 | <1% | 2,492 | $0.05 | |
| 90671 | <1% | 362 | $0.01 | |
| 90648 | 0% | 565 | $0.00 | |
| 90710 | 0% | 552 | $0.00 | |
| 90715 | 0% | 546 | $0.00 | |
| 90700 | 0% | 527 | $0.00 | |
| 90707 | 0% | 604 | $0.00 | |
| 90685 | 0% | 828 | $0.00 | |
| 90681 | 0% | 34 | $0.00 | |
| 91300 | 0% | 630 | $0.00 | |
| 90380 | 0% | 18 | $0.00 | |
| 3008F | 0% | 1,024 | $0.00 | |
| 90698 | 0% | 2,194 | $0.00 | |
| 90744 | 0% | 1,409 | $0.00 | |
| 91307 | 0% | 253 | $0.00 | |
| 90696 | 0% | 450 | $0.00 | |
| 90680 | 0% | 3,343 | $0.00 | |
| 90677 | 0% | 502 | $0.00 | |
| 90697 | 0% | 1,535 | $0.00 | |
| 99000 | 0% | 214 | $0.00 | |
| 90619 | 0% | 402 | $0.00 | |
| 90716 | 0% | 596 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJOHNSON, CARMEN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Johnson-Shone Dentistry LLC | Whiteland, IN | $243K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.